Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
PDF 33kWORD 18k
25 February 2020
E-003831/2019(ASW)
Answer given by Vice-President Šefčovič
on behalf of the European Commission
Question reference: E-003831/2019

The Commission was provided by the Secretary-General of the Council of the European Union with both the public and the confidential versions of Member States’ offers to host the European Medicines Agency (EMA).

The offer from the Netherlands for the EMA can be found on the website of the Council of the European Union , including the part of the offer which initially the Netherlands had wished to keep confidential but in the meantime decided to make publicly available(1).

The Dutch authorities handed over the EMA’s permanent building in Amsterdam Zuidas to the EMA on 15 November 2019.

The EMA finalised the staff relocation to this new building during the week of 20 January 2020 and the first committee meetings have already taken place in the new building.

(1)http://www.consilium.europa.eu/en/policies/relocation-london-agencies-brexit/
Last updated: 25 February 2020Legal notice - Privacy policy